SRK Pharmaceuticals

Lower Parel, Mumbai, Maharashtra

BirthCare Plus- Protein Supplement (A gentle care of 9 Months).SRK Pharmaceuticals-Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has notbeen approved by FDA. For further information about unapproved drugs, click here.Active ingredient (per 100 gm of BirthCare Plus)-Energy Value 397.5 (Kcal)Carbohydrate 78.5 gSugar 69.0 gDietary Fiber 0.0 mgTotal Fat 1.29 gSaturated Fat 1.22 gMono unsaturated Fatty Acids 0.0gmPoly unsaturated Fatty Acids 0.07 gCholesterol 0.0mgTrans Fatty Acids 0.0mgProtein 20% 18.0 gSodium Contents 0.35 mgVitamin C (Ascorbic Acid) 50.0 mgVitamin A 6.0 mgVitamin B1 (Thiamine) 3.0 mgVitamin B2 (Riboflavin) 3.0 mgVitamin B3 (Niacinamide) 20.0 mgVitamin B5 (Calcium D Pantothenate) 5.0 mgVitamin B12 3.0 mgCalcium Minerals 650.0 mgPhosphorus 425.0 mgIron 10.0 mgZinc 10.0 mgDirection-2-3 Full spoons of BirthCare Plus in glass of Milk, twice a day.Warning-Do not take exceed doses, consult your Gynecologist.

We are supplying sildenafil citrate as naturge x brand name an oral therapy for erectile dysfunction, is the citrate salt of sildenafil, a selective inhibitor of cyclic guanosine monophosphate.

we are offering cough syrup.

We are offering antacids capsules.

qualitative and quantitative composition

each tablet contains 200mg cefixime (anhydrous).

it is an orally active cephalosporin antibiotic which has marked in vitro bactericidal activity against a wide variety of gram-positive and gram-negative organisms.

it is indicated for the treatment of the following acute infections when caused by susceptible micro-organisms:

upper respiratory tract infections (urti): e.g. Otitis media; and other urti where the causative organism is known or suspected to be resistant to other commonly used antibiotics, or where treatment failure may carry significant risk.

lower respiratory tract infection: e.g. Bronchitis.

urinary tract infections: e.g. Cystitis, cystourethritis, uncomplicated pyelonephritis.

clinical efficacy has been demonstrated in infections caused by commonly occuring pathogens including streptococcus pneumoniae, streptococcus pyogenes, escherichia coli, proteus mirabilis, kliebsiella species, haemophilus influenzae (beta-lactamase positive and negative), branhamella catarrhalis (beta- lactamase positive and negative) and enterobacter species. Suprax is highly stable in the presence of beta-lactamase enzymes.

most strains of enterococci (streptococcus faecalis, group d streptococci) and staphylococci (including coagulase positive and negative strains and meticillin- resistant strains) are resistant to suprax. In addition, most strains of pseudomonas, bacteriodes fragalis, listeria monocytogenes and clostridia are resistant to suprax.

Each film-coated tablet contains 400 mg of ofloxacin.

Excipient with known effect:

Each film-coated tablet also contains 228.00 mg of lactose, anhydrous.

The following indications are restricted to adults.

Ofloxacin is suitable for treatment of the following bacterial infections if these are caused by pathogens sensitive to ofloxacin

Lower respiratory tract infections including pneumonia, bronchitits and acute exacerbations of chronic bronchitis caused by gram negative aerobic bacteria. (Ofloxacin tablets are not the drug of first choice in pneumonia caused by Streptococcus pneumoniae, Mycoplasma pneumoniae or Chlamydia pneumoniae);

Upper and lower urinary tract infections, including uncomplicated (cystitis) and complicated urinary tract infections.

Uncomplicated urethral and cervical gonorrhoea, non-gonococcal urethritis and cervicitis.

Consideration should be given to official guidance on the appropriate use of anti-bacterial agents.

Posology

The dose of ofloxacin is determined by the type and severity of the infection. The dosage range for adults is 200 mg to 800 mg daily.

Up to 400 mg may be given as a single dose, preferably in the morning. Generally, individual doses should be given at approximately equal intervals.

In individual cases it may be necessary to increase the dose to a maximum total dose of 800 mg daily, which should be given as 400 mg twice daily, at approximately equal intervals. This may be appropriate in infections due to pathogens known to have reduced or variable susceptibility to ofloxacin, in severe and/or complicated infections (e.g. of the respiratory or urinary tracts) or if the patient does not respond adequately.

Mechanism of action

Ofloxacin inhibits bacterial DNA replication by inhibiting bacterial topoisomerases, particularly DNA gyrase and topoisomerase IV. It is active after oral administration.

Therapeutic doses of ofloxacin are devoid of pharmacological effects on the voluntary or autonomic nervous system.

The NCCLS MIC breakpoint recommendations are as follows:

S 2 mg/l and R 8 mg/l

Intermediate susceptibility at 4 mg/l

Haemophilus influenzae and Neissaria gonorrhoea are exceptions with breakpoints at S 0.25 mg/l and R 1 mg/l

The BSAC general recommendations are S 2 mg/l and R 4 mg/l

According to DIN 58 940, the following limits apply for ofloxacin:

S mg/L, I = 3 mg/L, R 4 mg/L.

The prevalence of resistance may vary geographically and with time for selected species and local information on resistance is desirable, particularly when treating severe infections. This information gives only an approximate guidance on probabilities whether micro-organisms will be susceptible to ofloxacin or not.

Only those pathogens relevant to the indications are listed.

each film-coated tablet contains amoxicillin trihydrate equivalent to 500 mg amoxicillin and potassium clavulanate equivalent to 125 mg of clavulanic acid.

indicated for the treatment of the following infections in adults and children-

acute bacterial sinusitis (adequately diagnosed)

acute otitis media

acute exacerbations of chronic bronchitis (adequately diagnosed)

community acquired pneumonia

cystitis

pyelonephritis

skin and soft tissue infections in particular cellulitis, animal bites, severe dental abscess with spreading cellulitis.

bone and joint infections, in particular osteomyelitis.

consideration should be given to official guidance on the appropriate use of antibacterial agents.

posology

doses are expressed throughout in terms of amoxicillin/clavulanic acid content except when doses are stated in terms of an individual component.

the dose of augmentin that is selected to treat an individual infection should take into account:

the expected pathogens and their likely susceptibility to antibacterial agents (see section 4.4)

the severity and the site of the infection

the age, weight and renal function of the patient as shown below.

the use of alternative presentations of augmentin (e.g. Those that provide higher doses of amoxicillin and/or different ratios of amoxicillin to clavulanic acid) should be considered as necessary (see sections 4.4 and 5.1).

for adults and children 40 kg, this formulation of augmentin provides a total daily dose of 1500 mg amoxicillin/375 mg clavulanic acid, when administered as recommended below. For children < 40 kg, this formulation of augmentin provides a maximum daily dose of 2400 mg amoxicillin/600 mg clavulanic acid, when administered as recommended below. If it is considered that a higher daily dose of amoxicillin is required, it is recommended that another preparation of augmentin is selected in order to avoid administration of unnecessarily high daily doses of clavulanic acid (see sections 4.4 and 5.1).

the duration of therapy should be determined by the response of the patient. Some infections (e.g. Osteomyelitis) require longer periods of treatment. Treatment should not be extended beyond 14 days without review (see section 4.4 regarding prolonged therapy).

shelf life

Technology to inject drugs into the body is a recent development. Hypodermic syringes (hypodermic means beneath the skin) consist of a hollow needle attached to a syringe. They pierce the skin and inject substances into the bloodstream. They are also used to extract liquid such as blood from the body.

Dextrose Monohydrate(D-glucose) is a sugar that's a stable, odorless, white crystalline powder or colorless crystal.In its pure form, it has a dextrose equivalency (DE) of 100, which indicates that it's 100% pure Dextrose, not a mixture with other substances as well. It is extensively used in food industry and can provide support in replacing sucrose in baking, dairy products, canned products, chewing gum and preserves. Other than this, it is also used in beverage powders, in caramel coloring and other compositions where it supports extended shelf life of the products. The presence of dextrose also supports keeping powdered beverage drinks free flowing. Our Dextrose is made from non-GMO rice.

At present, we manufacture DMH at Muzaffarnagar facility of the Company. Offered product is appreciated and accepted in the market for its effectiveness & enhanced shelf life.

Uses

• Dextrose Monohydrateis used in the production of baked goods, candy and gum, creams and frozen dairy products (like some ice-creams and frozen yogurts), alcoholic beverages, jarred and canned foods.
• It is used as energy food by convalescing patient, sportsperson, children etc. and known to give instant energy and vigour.
• Dextrose is used in fruit and vegetable processing to help keep them fresh. It's also used in dehydration.
• It isused as a preservative as it doesn't alter the natural flavor of the food, especially compared to using sugar, another useful preservative
• Applications of Dextrose Monohydrate

  • It is a sweetner with sweetness of about 75% of the sucrose.
  • It is used as flavour to the food preparations when added alone or in combination with other weetener.
  • It is the simplest carbon source monosaccharide and used extensively in fermentation process for rapid growth with excellent yield, no non-fermentable sugars, low level of trace minerals organics, few leftovers to purify and consistency.
  • It is used in extending shelf life of many food products.

We are offering we are supplying the best quality of disposable syringes. Size range from 1-60ml, with and without needle.

intravenous (iv) cannulation is a technique in which a cannula is placed inside a vein to provide venous access. Venous access allows sampling of blood, as well as administration of fluids, medications, parenteral nutrition, chemotherapy, and blood products.

veins have a three-layered wall composed of an internal endothelium surrounded by a thin layer of muscle fibers that is surrounded by a layer of connective tissue. Venous valves encourage unidirectional flow of blood and prevent pooling of blood in the dependent portions of the extremities; they also can impede the passage of a catheter through and into a vein. Venous valves are more numerous just distal to the points where tributaries join larger veins and in the lower extremities.

medication, fluid and blood are some of those terms that can be received easily into the blood stream using the iv cannula. The iv cannula generally are believed to be of three types and they are peripheral iv cannula, the central line iv cannula and the last but not the least the midline iv cannula

50ml, 100ml, 200ml, 1000ml

hand sanitizer kills 99.9% of germs instantly, without water. Use anytime, anywhere: while in car, office, handbag, picnics, nappy change, travel, sports etc. Leaves your hands refreshed. Use as often as required.

pure type I collagen, gama sterilized, with vitamin d, muprocin combination . Easy to use and 120% safe. Biocompatable and very effective. Use powder direct on wound site and close for 2 days.

COVID KIT CITRA APPROVED

.

A highly effective inhibitor of gastric acid secretion used in the therapy of stomach ulcers and Zollinger-Ellison syndrome. Omeprazole belongs to a class of antisecretory compounds, the substituted benzimidazoles, that suppress gastric acid secretion by specific inhibition of the H+K+ ATPase enzyme system at the secretory surface of the gastric parietal cell

the vibro sifter machine works on the principle of gyratory vibrations. The material is separated on the basis of their particle size. Once the motor gets energized, vibration is caused in the screen/sieve making the material to travel across the sieves according to its particle size.